Aegerion Pharmaceuticals to Announce Second-Quarte

CAMBRIDGE, Mass., July 12, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc.  (Nasdaq: AEGR ), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, often fatal, rare diseases, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. EDT on Tuesday, July 30, 2013, to provide a business update and to discuss its second-quarter financial and operational results.

To listen to the live webcast of the call, please visit the "Investors" section of the Company's website at www.aegerion.com . Individuals may also participate in the call via telephone by dialing (866) 516-3002 or (760) 298-5082. Interested parties unable to join the live call may access an archived version of the webcast on Aegerion's website for up to 30 days following the call.

About Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, often fatal, rare diseases. For more information about the company, please visit www.aegerion.com .

Aegerion Pharmaceuticals, Inc. Amanda Murphy, Manager, IR 857-242-5024